[New European approvals: Pemigatinib – cholangiocarcinoma with a FGFR2 fusion or
- This topic has 0 replies, 1 voice, and was last updated 2 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
[New European approvals: Pemigatinib – cholangiocarcinoma with a FGFR2 fusion or rearrangement]
https://pubmed.ncbi.nlm.nih.gov/33931169/
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.